Intuitive Surgical [ISRG] vs West Pharmaceutical [WST] Detailed Stock Comparison
Intuitive Surgical
NASDAQ
Loading...
West Pharmaceutical
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Intuitive Surgical wins in 8 metrics, West Pharmaceutical wins in 11 metrics, with 0 ties. West Pharmaceutical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Intuitive Surgical | West Pharmaceutical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 61.34 | 40.57 | West Pharmaceutical |
| Price-to-Book Ratio | 8.82 | 6.66 | West Pharmaceutical |
| Debt-to-Equity Ratio | 0.00 | 10.52 | Intuitive Surgical |
| PEG Ratio | 2.52 | 2.06 | West Pharmaceutical |
| EV/EBITDA | 47.79 | 23.64 | West Pharmaceutical |
| Profit Margin (TTM) | 28.51% | 16.48% | Intuitive Surgical |
| Operating Margin (TTM) | 30.47% | 20.87% | Intuitive Surgical |
| EBITDA Margin (TTM) | 30.47% | 20.87% | Intuitive Surgical |
| Return on Equity | 16.04% | 17.72% | West Pharmaceutical |
| Return on Assets (TTM) | 9.02% | 10.53% | West Pharmaceutical |
| Free Cash Flow (TTM) | $1.30B | $276.40M | Intuitive Surgical |
| Dividend Yield | N/A | 0.38% | N/A |
| 1-Year Return | -8.08% | -7.87% | West Pharmaceutical |
| Price-to-Sales Ratio (TTM) | 17.29 | 6.59 | West Pharmaceutical |
| Enterprise Value | $152.23B | $18.66B | Intuitive Surgical |
| EV/Revenue Ratio | 16.65 | 6.30 | West Pharmaceutical |
| Gross Profit Margin (TTM) | 66.31% | 35.73% | Intuitive Surgical |
| Revenue per Share (TTM) | $26 | $41 | West Pharmaceutical |
| Earnings per Share (Diluted) | $7.16 | $6.69 | Intuitive Surgical |
| Beta (Stock Volatility) | 1.62 | 1.05 | West Pharmaceutical |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Intuitive Surgical vs West Pharmaceutical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Intuitive Surgical | 1.13% | 1.12% | -5.56% | -18.05% | -12.63% | -15.46% |
| West Pharmaceutical | 0.64% | 7.34% | 12.07% | 23.48% | 23.32% | -16.82% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Intuitive Surgical | -8.08% | 134.79% | 80.04% | 749.00% | 1,275.81% | 5,565.09% |
| West Pharmaceutical | -7.87% | 9.34% | -8.42% | 397.65% | 1,455.58% | 1,825.02% |
News Based Sentiment: Intuitive Surgical vs West Pharmaceutical
Intuitive Surgical
News based Sentiment: MIXED
September presented a mixed bag for Intuitive Surgical, with positive developments in the SP platform and long-term projections offset by a stock downgrade, price decline, and ongoing tariff concerns. The company is navigating a complex environment, making this a significant month for investors to reassess their positions.
West Pharmaceutical
News based Sentiment: POSITIVE
West Pharmaceutical Services reported strong Q2 results, exceeding both earnings and revenue estimates, and reaffirmed its full-year guidance. This positive performance has led to increased price targets from analysts and inclusion in a high-growth dividend stock list, signaling a generally positive outlook for the company.
Performance & Financial Health Analysis: Intuitive Surgical vs West Pharmaceutical
| Metric | ISRG | WST |
|---|---|---|
| Market Information | ||
| Market Cap | $157.45B | $19.61B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 2,576,570 | 663,147 |
| 90 Day Avg. Volume | 2,410,430 | 588,086 |
| Last Close | $443.01 | $273.16 |
| 52 Week Range | $425.00 - $616.00 | $187.43 - $352.33 |
| % from 52W High | -28.08% | -22.47% |
| All-Time High | $616.00 (Jan 20, 2025) | $475.35 (Sep 06, 2021) |
| % from All-Time High | -28.08% | -42.53% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.21% | 0.09% |
| Quarterly Earnings Growth | 0.25% | 0.18% |
| Financial Health | ||
| Profit Margin (TTM) | 0.29% | 0.16% |
| Operating Margin (TTM) | 0.30% | 0.21% |
| Return on Equity (TTM) | 0.16% | 0.18% |
| Debt to Equity (MRQ) | 0.00 | 10.52 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $49.79 | $40.74 |
| Cash per Share (MRQ) | $14.86 | $7.09 |
| Operating Cash Flow (TTM) | $2.83B | $676.70M |
| Levered Free Cash Flow (TTM) | $1.82B | $207.85M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.38% |
| Last 12-Month Dividend | N/A | $0.83 |
Valuation & Enterprise Metrics Analysis: Intuitive Surgical vs West Pharmaceutical
| Metric | ISRG | WST |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 61.34 | 40.57 |
| Forward P/E | 55.88 | 36.09 |
| PEG Ratio | 2.52 | 2.06 |
| Price to Sales (TTM) | 17.29 | 6.59 |
| Price to Book (MRQ) | 8.82 | 6.66 |
| Market Capitalization | ||
| Market Capitalization | $157.45B | $19.61B |
| Enterprise Value | $152.23B | $18.66B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 16.65 | 6.30 |
| Enterprise to EBITDA | 47.79 | 23.64 |
| Risk & Other Metrics | ||
| Beta | 1.62 | 1.05 |
| Book Value per Share (MRQ) | $49.79 | $40.74 |
Financial Statements Comparison: Intuitive Surgical vs West Pharmaceutical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ISRG | WST |
|---|---|---|
| Revenue/Sales | $2.44B | $766.50M |
| Cost of Goods Sold | $822.10M | $492.60M |
| Gross Profit | $1.62B | $273.90M |
| Research & Development | $313.30M | $19.10M |
| Operating Income (EBIT) | $743.40M | $158.90M |
| EBITDA | $898.70M | $203.40M |
| Pre-Tax Income | $832.10M | $157.00M |
| Income Tax | $167.90M | $30.20M |
| Net Income (Profit) | $664.20M | $131.80M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ISRG | WST |
|---|---|---|
| Cash & Equivalents | $2.57B | $509.70M |
| Total Current Assets | $7.66B | $1.68B |
| Total Current Liabilities | $1.54B | $604.60M |
| Long-Term Debt | N/A | $282.40M |
| Total Shareholders Equity | $17.21B | $2.93B |
| Retained Earnings | $7.14B | $4.14B |
| Property, Plant & Equipment | N/A | $3.28B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ISRG | WST |
|---|---|---|
| Operating Cash Flow | $833.10M | $177.40M |
| Capital Expenditures | $-116.60M | N/A |
| Free Cash Flow | $465.00M | $101.90M |
| Debt Repayment | N/A | $-300,000 |
| Common Stock Repurchase | N/A | $-500,000 |
Short Interest & Institutional Ownership Analysis
| Metric | ISRG | WST |
|---|---|---|
| Shares Short | 5.72M | 1.68M |
| Short Ratio | 2.50 | 2.92 |
| Short % of Float | 0.02% | 0.03% |
| Average Daily Volume (10 Day) | 2,576,570 | 663,147 |
| Average Daily Volume (90 Day) | 2,410,430 | 588,086 |
| Shares Outstanding | 356.60M | 72.30M |
| Float Shares | 356.30M | 71.41M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 0.89% | 0.98% |
Dividend Analysis & Yield Comparison: Intuitive Surgical vs West Pharmaceutical
| Metric | ISRG | WST |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.83 |
| Last 12-Month Dividend Yield | N/A | 0.38% |
| 3-Year Avg Annual Dividend | N/A | $0.79 |
| 3-Year Avg Dividend Yield | N/A | 0.07% |
| 3-Year Total Dividends | N/A | $2.37 |
| Ex-Dividend Date | N/A | Apr 30, 2025 |